Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1847.58%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 16.04M | 1847.58% | $ 868K |
| 3/31/2025 | $ 15.52M | 837.74% | $ 1.85M |
| 12/31/2024 | $ 15.13M | 667.65% | $ 2.27M |
| 9/30/2024 | $ 14.53M | 638.49% | $ 2.28M |
| 6/30/2024 | $ 13.99M | 582.36% | $ 2.4M |
| 3/31/2024 | $ 13.55M | 771.81% | $ 1.76M |
| 12/31/2023 | $ 13.31M | 964.78% | $ 1.38M |
| 9/30/2023 | $ 13.84M | 1114.33% | $ 1.24M |
| 6/30/2023 | $ 13.46M | 1297.21% | $ 1.04M |
| 3/31/2023 | $ 11.79M | 2029.6% | $ 581K |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average Int. Exp. % has been 1350.74%.
- The median Int. Exp. % for BIOXCEL THERAPEUTICS INC during this period was 1039.56%
- BIOXCEL THERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 3267.15%.
- The lowest Int. Exp. % recorded by BIOXCEL THERAPEUTICS INC in the same timeframe 582.36%
BIOXCEL THERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for BIOXCEL THERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 5K ] / Revenues [ $ 0 ]
(=) Int. Exp. % [ 0% ] BTAI - Interest Expense Margin, Last 5 years
582.36%
Minimum
Jun 30, 2024
3267.15%
Maximum
Sep 30, 2022
1350.74%
Average
1039.56%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |